404 related articles for article (PubMed ID: 37508557)
1. Bile Acids, Intestinal Barrier Dysfunction, and Related Diseases.
Shi L; Jin L; Huang W
Cells; 2023 Jul; 12(14):. PubMed ID: 37508557
[TBL] [Abstract][Full Text] [Related]
2. Interplay between bile acids and the gut microbiota promotes intestinal carcinogenesis.
Wang S; Dong W; Liu L; Xu M; Wang Y; Liu T; Zhang Y; Wang B; Cao H
Mol Carcinog; 2019 Jul; 58(7):1155-1167. PubMed ID: 30828892
[TBL] [Abstract][Full Text] [Related]
3. Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside.
Yang M; Gu Y; Li L; Liu T; Song X; Sun Y; Cao X; Wang B; Jiang K; Cao H
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579027
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis.
Cai J; Sun L; Gonzalez FJ
Cell Host Microbe; 2022 Mar; 30(3):289-300. PubMed ID: 35271802
[TBL] [Abstract][Full Text] [Related]
5. The Role of the Gut Microbiota in Bile Acid Metabolism.
Ramírez-Pérez O; Cruz-Ramón V; Chinchilla-López P; Méndez-Sánchez N
Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s15-s20. PubMed ID: 29080339
[TBL] [Abstract][Full Text] [Related]
6. Signaling from Intestine to the Host: How Bile Acids Regulate Intestinal and Liver Immunity.
Biagioli M; Carino A
Handb Exp Pharmacol; 2019; 256():95-108. PubMed ID: 31119464
[TBL] [Abstract][Full Text] [Related]
7. Consequences of bile salt biotransformations by intestinal bacteria.
Ridlon JM; Harris SC; Bhowmik S; Kang DJ; Hylemon PB
Gut Microbes; 2016; 7(1):22-39. PubMed ID: 26939849
[TBL] [Abstract][Full Text] [Related]
8. Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.
Kumar A; Al-Hassi HO; Steed H; Phipps O; Brookes MJ
Can J Gastroenterol Hepatol; 2022; 2022():8416578. PubMed ID: 35360442
[TBL] [Abstract][Full Text] [Related]
9. Bile Acids Activated Receptors Regulate Innate Immunity.
Fiorucci S; Biagioli M; Zampella A; Distrutti E
Front Immunol; 2018; 9():1853. PubMed ID: 30150987
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota-bile acid-intestinal Farnesoid X receptor signaling axis orchestrates cadmium-induced liver injury.
Liu Y; Kang W; Liu S; Li J; Liu J; Chen X; Gan F; Huang K
Sci Total Environ; 2022 Nov; 849():157861. PubMed ID: 35934034
[TBL] [Abstract][Full Text] [Related]
11. Bile acids and their receptors: Potential therapeutic targets in inflammatory bowel disease.
Long XQ; Liu MZ; Liu ZH; Xia LZ; Lu SP; Xu XP; Wu MH
World J Gastroenterol; 2023 Jul; 29(27):4252-4270. PubMed ID: 37545642
[TBL] [Abstract][Full Text] [Related]
12. Intestinal crosstalk between bile acids and microbiota in irritable bowel syndrome.
Deng X; Xiao L; Luo M; Xie P; Xiong L
J Gastroenterol Hepatol; 2023 Jul; 38(7):1072-1082. PubMed ID: 36869260
[TBL] [Abstract][Full Text] [Related]
13. Review article: insights into the bile acid-gut microbiota axis in intestinal failure-associated liver disease-redefining the treatment approach.
Wang Y; Zheng L; Zhou Z; Yao D; Huang Y; Liu B; Duan Y; Li Y
Aliment Pharmacol Ther; 2022 Jan; 55(1):49-63. PubMed ID: 34713470
[TBL] [Abstract][Full Text] [Related]
14. Gut microbiota inhibit Asbt-dependent intestinal bile acid reabsorption via Gata4.
Out C; Patankar JV; Doktorova M; Boesjes M; Bos T; de Boer S; Havinga R; Wolters H; Boverhof R; van Dijk TH; Smoczek A; Bleich A; Sachdev V; Kratky D; Kuipers F; Verkade HJ; Groen AK
J Hepatol; 2015 Sep; 63(3):697-704. PubMed ID: 26022694
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiota at the intersection of bile acids and intestinal carcinogenesis: An old story, yet mesmerizing.
Liu T; Song X; Khan S; Li Y; Guo Z; Li C; Wang S; Dong W; Liu W; Wang B; Cao H
Int J Cancer; 2020 Apr; 146(7):1780-1790. PubMed ID: 31291465
[TBL] [Abstract][Full Text] [Related]
16. Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation.
Gasaly N; de Vos P; Hermoso MA
Front Immunol; 2021; 12():658354. PubMed ID: 34122415
[TBL] [Abstract][Full Text] [Related]
17. Crosstalk between Gut Microbiota and Bile Acids in Cholestatic Liver Disease.
Shi Q; Yuan X; Zeng Y; Wang J; Zhang Y; Xue C; Li L
Nutrients; 2023 May; 15(10):. PubMed ID: 37242293
[TBL] [Abstract][Full Text] [Related]
18. The Emerging Role of Bile Acids in the Pathogenesis of Inflammatory Bowel Disease.
Thomas JP; Modos D; Rushbrook SM; Powell N; Korcsmaros T
Front Immunol; 2022; 13():829525. PubMed ID: 35185922
[TBL] [Abstract][Full Text] [Related]
19. Impact of Primary and Secondary Bile Acids on
Łukawska A; Mulak A
Pol J Microbiol; 2022 Mar; 71(1):11-18. PubMed ID: 35635171
[TBL] [Abstract][Full Text] [Related]
20. [Mechanism of gut-microbiota-liver axis in the pathogenesis of intestinal failure-associated liver disease].
Fan SX; Wang J; Li Q; Li YS; Guan WX; Li JS
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Jan; 24(1):94-100. PubMed ID: 33461259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
